Quick facts
- An eye pad, also written eye dressing pad, is an absorbent pad placed over a closed eyelid after surgery, a foreign-body removal or a minor procedure. It absorbs, and it cushions. It does not occlude vision on its own.
- United States: a general eye pad has no named entry. The only named pad entry is for a neonatal eye pad, 21 CFR 880.5270, Class I. The cover worn above the pad has its own entry, the ophthalmic eye shield, 21 CFR 886.4750, Class I.
- Canada: the class is derived, not named. A non-invasive device intended to act as a mechanical barrier or for the absorption of exudations is Class I under Rule 4(2) of Schedule 1 to the Medical Devices Regulations, SOR/98-282.
- A sterile label changes obligations, not class. Both United States exemptions are written around devices that are not labelled sterile.
- Pad, patch and shield are three products. A patch occludes for amblyopia therapy, a pad absorbs, a shield protects and retains the pad.
- The purchase test is a label test: intended use, sterility, size, materials and single-use status, read in that order.
An eye pad is one of the least expensive items on an ophthalmic tray, which is exactly why it is usually bought without a specification. The product is regulated in both countries, but neither country regulates the plain gauze version as a named device, and that gap is what a procurement decision has to work around. This article sets out what the pad does, how each country classifies it, how the pad differs from the patch and the shield beside it, what has to be recorded, and how a clinic should specify and stock the line.
What is an eye pad, and what is it made of?
An eye pad is a layered absorbent dressing. The common build is a folded gauze square, sterile or non-sterile, sometimes with a soft outer facing and a shaped oval cut so it sits over the closed lid without pressing on the globe. It is held in place by tape, or by a plastic or aluminium shield placed above it.
Three properties decide what the pad is for:
- Absorbency. The pad takes up exudate and blood after a lid procedure, a chalazion incision or a foreign-body removal.
- Cushioning. The pad spreads pressure from the tape or shield away from the globe.
- Single-use status. A pad is a single-use item in practice. Even where the material could be cleaned, the absorptive layer cannot be restored.
The pad is not the same thing as a protective shield. 21 CFR 886.4750 describes the shield as "a plastic or aluminum eye covering intended to protect the eye or retain dressing materials in place". That last clause is the reason the two products are bought together: the shield is the retention system, the pad is the dressing it retains.
How do Canada and the United States classify an eye pad differently?
Both systems reach the same answer for the plain product, by two different routes.
| Item | Canada | United States |
|---|---|---|
| Named entry for a general eye pad | None; class derived by rule | None |
| Named entry for a neonatal eye pad | None; class derived by rule | 21 CFR 880.5270, Class I |
| Class of a pad used as a barrier or for absorption | Class I, Rule 4(2) | Class I (general controls) |
| Named entry for the cover worn above the pad | None; class derived by rule | 21 CFR 886.4750, ophthalmic eye shield, Class I |
| Premarket position for the cover | Licence only where the derived class requires one | Exempt from premarket notification, subject to § 886.9 |
| What a sterile label changes | Licence and quality system obligations follow class and claim | The exemption in the section falls away |
| Plain gauze pad, no medical claim | Not a medical device | Not a medical device |
The Canadian rule is the one to read closely, because it is written as a fallback. Rule 4(1) sends a non-invasive device that is intended to come into contact with injured skin to Class II. Rule 4(2) pulls it back to Class I when it "is intended to be used as a mechanical barrier, for compression or for absorption of exudations". A dressing is the example the rule is drawn around, and an eye pad is a dressing.
The United States route is narrower and more literal. 21 CFR 880.5270 identifies the neonatal eye pad as "an opaque device used to cover and protect the eye of an infant during therapeutic procedures, such as phototherapy". It is an entry for an infant pad under a light, not for a postoperative adult dressing. An adult eye pad sold into the United States therefore rides on the general dressing and bandage provisions rather than on an eye-specific section, which is why the shield entry beside it matters so much: it is the only eye-specific wording in the pair.
Are eye pads regulated the same way in Canada and the United States when no claim is made?
No, and the divergence is instructive. The question in both systems is whether the article makes a medical claim at all.
- Canada. The Medical Devices Regulations apply to an article that falls within the definition of a medical device and is sold for a medical purpose. A plain gauze square sold as general first-aid stock, with no intended-use statement that ties it to the eye, is a consumer or general article. There is no eye pad entry to attach to, so nothing draws it in.
- United States. 21 CFR 880.5270 is likewise claim-driven. A pad that is not labelled and not promoted for a specific medical use does not sit in the device section at all.
The practical consequence is the same on both sides of the border. The moment a supplier writes "ophthalmic dressing", "post-operative eye pad" or "sterile eye pad" on the label or the listing, the article becomes a regulated device and the label becomes the specification. That is why the intended-use line, not the price, is the first thing to read on a quotation.
Sterility is the second lever. Both the neonatal pad section and the shield section write their exemptions around products that are not labelled sterile. A clinic that buys a non-sterile pad for a closed-lid dressing and a sterile pad for an open wound is buying two different regulatory positions, and the label has to be read to tell them apart.
Which pad does a Canadian clinic buy for a post-operative dressing?
Four shapes cover almost all routine work, and each answers a different question.
| Pad format | What it suits | What the label has to state |
|---|---|---|
| Folded gauze square, non-sterile | A closed-lid dressing after a minor lid procedure | Size in centimetres, ply, non-sterile |
| Sterile oval eye pad | A dressing left in place after an incision | Sterile, single use, expiry |
| Adhesive-backed eye pad | A dressing that has to stay put without separate tape | Adhesive type, skin suitability |
| Neonatal eye pad | Covering an infant's eye during phototherapy | Opaque, infant size, single use |
A buyer who orders on size alone will receive four products that behave differently. An adhesive-backed pad and a plain square differ in how long they can stay in place, and a neonatal pad is opaque for a stated therapeutic reason rather than for a wound. Under Canada's Rule 4(1) and 4(2) split, the pad that contacts injured skin as a barrier stays in Class I, while a pad promoted to deliver something to the skin, such as an impregnated medicated pad, leaves the dressing rule entirely.
How is an eye pad recorded and disposed of?
An eye pad is a single-use item, and a clinic that tracks single-use devices as part of its infection prevention and control programme will treat a pad as low-risk for reprocessing but not for documentation. Two records matter:
- What went on the patient and when. After an ophthalmic procedure, the dressing applied, the person who applied it and the instructions given to the patient are part of the procedure record.
- What came off and how it was discarded. A used pad is contaminated waste, and it goes into the clinical waste stream that the facility's waste policy defines.
The College of Optometrists of Ontario standards and the Canadian Ophthalmological Society material both treat the dressing as part of the procedure, not as stock. Detailed infection control expectations for examination rooms sit with Public Health Ontario, and workplace handling of contaminated items sits with CCOHS.
Which consumables does an eye clinic lane go through?
A dressing is never bought alone. A typical lane restocks gauze pads, tape, an eye shield or eye mask, cotton swabs, exam table paper, gloves and a surface disinfectant in the same cycle. For practices buying at case level, the wholesale ordering page sets out account and case pricing, and the B2B wholesale collection lists the lines held for institutional buyers. A warm compress eye mask is the companion item most often specified with a dressing routine, and the graphene USB heated eye mask is the line we hold for that use. Lanes that also run an in-house sterilizer for reusable instruments can begin with the biological indicator 5-pack trial and read the sterilization monitoring collection for the monitoring lines.
Sources
- 21 CFR 880.5270, neonatal eye pad
- 21 CFR 886.4750, ophthalmic eye shield
- Medical Devices Regulations, SOR/98-282, full text, Schedule 1
- Health Canada, medical devices
- openFDA device classification database
- College of Optometrists of Ontario
- Opto, Canadian Association of Optometrists eye health library
- American Academy of Ophthalmology, eye health
- Canadian Ophthalmological Society
- American Optometric Association, healthy eyes
- Public Health Ontario, infectious diseases
- CCOHS, osh answers
- World Health Organization, eye care
- National Eye Institute, eye health information
- Health Canada, medical device regulations
- Clinical and Laboratory Standards Institute
- FDA device classification database search
- HealthyChildren.org, eye conditions and vision, American Academy of Pediatrics
- Ontario Ministry of Health
- American Association for Pediatric Ophthalmology and Strabismus, eye glossary
Related reading
- Eye patches in Canada vs the US: types, coverage and clinical use
- Eye shields in Canada vs the US: which device rules apply
- Eye clinic consumables: gloves, swabs and tape for optometry
- Face shield vs goggles: choosing eye protection for procedures
CliniEco Medical supplies eye care, laboratory and clinic consumables of the kind described in this article. Health Canada MDEL #35334. This article is written for clinic, procurement and eye care professionals and is not clinical guidance; dressing selection for a patient and post-operative instructions belong to the treating optometrist or physician.
Frequently Asked Questions
Is an eye pad a medical device in Canada?
It depends on the claim. A plain gauze square sold with no eye-related intended use is not drawn into the Medical Devices Regulations. Once a label states an ophthalmic dressing use, the pad is a non-invasive device and its class follows Schedule 1, with a pad used as a mechanical barrier or for absorption of exudations falling to Class I under Rule 4(2).
Does the United States have an eye pad entry?
Only one, and it is narrow. 21 CFR 880.5270 names a neonatal eye pad as an opaque device used to cover and protect an infant's eye during procedures such as phototherapy, and places it in Class I. An adult postoperative dressing has no eye-specific entry and relies on the general dressing provisions.
What is the difference between an eye pad, an eye patch and an eye shield?
A pad is an absorbent dressing laid over a closed lid. A patch is an occlusive device used in amblyopia therapy to block vision in one eye. A shield is a plastic or aluminium cover that protects the eye or retains dressing material in place, and it has its own entry at 21 CFR 886.4750.
Does a sterile label change the class of an eye pad?
No, it changes the obligations attached to that class. The exemptions written into 21 CFR 880.5270 and 21 CFR 886.4750 are drafted around devices that are not labelled sterile, so a sterile version carries the fuller quality system position even though the class stays Class I.
What should a Canadian clinic ask a supplier for when buying eye pads?
The intended-use statement, the sterility and single-use status, the size in centimetres and the material of each layer. Also ask which party holds the establishment licence for the product, since that obligation attaches to the manufacturer, importer or distributor rather than to the clinic.
How should used eye pads be handled?
As contaminated clinical waste, per the facility's waste policy. The pad is a single-use item and is not reprocessed. The procedure record should note the dressing applied and, where relevant, the instructions given to the patient.
0 commentaire